Barry D. Quart - 16 Mar 2026 Form 3 Insider Report for Connect Biopharma Holdings Ltd (CNTB)

Role
Chief Executive Officer, Director
Signature
/s/ Lisa Peraza attorney-in-fact for Barry D Quart
Issuer symbol
CNTB
Transactions as of
16 Mar 2026
Net transactions value
$0
Form type
3
Filing time
16 Mar 2026, 16:47:00 UTC
Previous filing
12 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Quart Barry D Chief Executive Officer, Director 3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO /s/ Lisa Peraza attorney-in-fact for Barry D Quart 16 Mar 2026 0001384243

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNTB Ordinary Shares 95,147 16 Mar 2026 Direct
holding CNTB Ordinary Shares 128,887 16 Mar 2026 By Joint Account with Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNTB Employee Stock Option (Right to Buy) 16 Mar 2026 Ordinary Shares 2,658,734 $1.77 Direct F1
holding CNTB Employee Stock Option (Right to Buy) 16 Mar 2026 Ordinary Shares 432,392 $0.9700 Direct F1
holding CNTB Employee Stock Option (Right to Buy) 16 Mar 2026 Ordinary Shares 700,000 $2.69 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable over four years, with 25% vesting on the first anniversary of the date of grant, and then with respect to the remaining shares on a ratable monthly basis over the next three years, subject to continuous service with the Company as of each applicable vesting date.
F2 The stock option vests and becomes exercisable on a ratable monthly basis over four years, subject to continuous service with the Company as of each applicable vesting date.